• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION V-14 CONTROL WIRE; WIRE, GUIDE, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION V-14 CONTROL WIRE; WIRE, GUIDE, CATHETER Back to Search Results
Model Number 40456
Device Problem Detachment of Device or Device Component (2907)
Patient Problem Device Embedded In Tissue or Plaque (3165)
Event Date 12/05/2018
Event Type  Injury  
Event Description
It was reported that the guidewire tip detached and remained in the patient.A v-14 control wire was selected for use for a percutaneous transluminal angioplasty (pta) procedure in the left distal fibularis to treat chronic total occlusion.The target lesion was not tortuous, however, the lesion was highly calcified and 100% stenosed.The physician attempted to recanalize the total occlusion.When the physician attempted to remove the wire, resistance was felt and the wire made a loop in the occluded segment of the lesion, and the wire tip became stuck.The physician attempted to pull the wire and 1-2 cm of the wire tip detached.The tip was detached in the area of total occlusion, so no attempts to retrieve the wire were made.The physician believes the tip detached due to the patient's underlying condition and anatomy characteristics, and there is no further intervention planned to retrieve the device fragment.There were no further patient complications reported.
 
Manufacturer Narrative
Device evaluated by mfr: investigation completed on returned device.Visual analysis revealed that the distal tip had a kink, and the distal coating of the wire was peeled off and missing.The core wire was not broken and remained in tact.There was no other damage or irregularities observed.
 
Event Description
It was reported that the guidewire tip detached and remained in the patient.A v-14 control wire was selected for use for a percutaneous transluminal angioplasty (pta) procedure in the left distal fibularis to treat chronic total occlusion.The target lesion was not tortuous, however, the lesion was highly calcified and 100% stenosed.The physician attempted to recanalize the total occlusion.When the physician attempted to remove the wire, resistance was felt and the wire made a loop in the occluded segment of the lesion, and the wire tip became stuck.The physician attempted to pull the wire and 1-2cm of the wire tip detached.The tip was detached in the area of total occlusion, so no attempts to retrieve the wire were made.The physician believes the tip detached due to the patient's underlying condition and anatomy characteristics, and there is no further intervention planned to retrieve the device fragment.There were no further patient complications reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
V-14 CONTROL WIRE
Type of Device
WIRE, GUIDE, CATHETER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key8169720
MDR Text Key130508984
Report Number2134265-2018-63923
Device Sequence Number1
Product Code DQX
UDI-Device Identifier08714729799221
UDI-Public08714729799221
Combination Product (y/n)N
PMA/PMN Number
K112745
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 01/29/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/16/2020
Device Model Number40456
Device Catalogue Number40456
Device Lot Number0022529032
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/04/2019
Initial Date Manufacturer Received 12/07/2018
Initial Date FDA Received12/17/2018
Supplement Dates Manufacturer Received01/28/2019
Supplement Dates FDA Received01/29/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-